Patent · US Active

Domain-swap T cell receptors

US9884075B2 · kind B2 · utility

5Cited by
1References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 15, 2015
Grant dateFeb 6, 2018
Priority date—
Expiry dateAug 6, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2239/58
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are genetically engineered T cell receptors, and methods, vectors, and genetically engineered T cells related to genetically engineered T cell receptors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.